Volume 13, Issue 4 (12-2025)                   JoMMID 2025, 13(4): 264-273 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nosrati M J, Koohsari H, Noryan M. Antibacterial activity of Sofoof polyherbal formulation against some gastrointestinal pathogens. JoMMID 2025; 13 (4) :264-273
URL: http://jommid.pasteur.ac.ir/article-1-722-en.html
Antibacterial activity of Sofoof polyherbal formulation against some gastrointestinal pathogens
Mohammad Javad Nosrati , Hadi Koohsari * , Morteza Noryan
Department of Microbiology, Az.C., Islamic Azad University, Azadshahr, Iran
Abstract:   (248 Views)
Introduction: The people of Forumad, a village in Semnan Province, Iran, have long used a polyherbal formulation called Sofoof to prevent and treat gastrointestinal disorders. This formulation comprises 11 medicinal plants: Carum carvi, Cuminum cyminum, Pimpinella anisum, Anethum graveolens, Achillea millefolium, Glycyrrhiza glabra, Artemisia absinthium, Terminalia chebula, Peganum harmala, Ferula communis, and Trachyspermum ammi. This study aimed to investigate the antibacterial activity of the Sofoof polyherbal formulation and its individual plant constituents against six species of gastrointestinal pathogenic bacteria. Methods: Extraction was performed using an infusion method with a solvent system of ethanol, 1-propanol, and water (1:1:1, v/v/v). Antibacterial activity was assessed using the agar well-diffusion assay, and the macrodilution method was used to determine the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC). Results: Extracts of T. chebula, P. harmala, and C. cyminum showed significant antibacterial activity. At a concentration of 31.25 mg/mL, the inhibition zone diameters of T. chebula extract against Escherichia coli, Salmonella typhimurium, Enterococcus faecalis, Shigella dysenteriae, Staphylococcus aureus, and Bacillus cereus were 13, 10, 13, 12, 29, and 24.5 mm, respectively. The MICs for T. chebula against these bacteria ranged from 0.98 mg/mL (Bacillus cereus) to 31.25 mg/mL (Shigella dysenteriae). Notably, the extract of the Sofoof polyherbal formulation (comprising 11 plants) showed lower antibacterial activity than the individual extracts of T. chebula and P. harmala. Conclusion: This study validates the traditional use of the Sofoof polyherbal formulation and identifies T. chebula, P. harmala, and C. cyminum as its most active antibacterial constituents. Gram-positive bacteria demonstrated greater susceptibility to the extracts than Gram-negative bacteria. The lower activity of the Sofoof polyherbal formulation compared to certain individual plant extracts suggests possible antagonistic interactions, warranting further studies to elucidate constituent interactions within polyherbal formulations.
 
Keywords: Antibacterial activity, Gastrointestinal pathogenic bacteria, Medicinal plants, Sofoof polyherbal formulation
Full-Text [PDF 755 kb]   (80 Downloads)    
Type of Study: Original article | Subject: Anti-microbial agents, resistance and treatment protocols
Received: 2025/03/28 | Accepted: 2025/12/10 | Published: 2026/02/3
References
1. Oyebode O, Kandala NB, Chilton PJ, Lilford RJ. Use of traditional medicine in middle-income countries: a WHO-SAGE study. Health Policy Plan. 2016; 31 (8): 984-91. [DOI:10.1093/heapol/czw022] [PMID] [PMCID]
2. Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspect. 2001; 109 (Suppl 1): 69-75. [DOI:10.1289/ehp.01109s169] [PMID] [PMCID]
3. Ngezahayo J, Havyarimana F, Hari L, Stévigny C, Duez P. Medicinal plants used by Burundian traditional healers for the treatment of microbial diseases. J Ethnopharmacol. 2015; 173: 338-51. [DOI:10.1016/j.jep.2015.07.028] [PMID]
4. Khayyal MT, el-Ghazaly MA, Kenawy SA, Seif-el-Nasr M, Mahran LG, Kafafi YA, et al. Antiulcerogenic effect of some gastrointestinally acting plant extracts and their combination. Arzneimittelforschung. 2001; 51 (7): 545-53. [DOI:10.1055/s-0031-1300078] [PMID]
5. Mabona U, Viljoen A, Shikanga E, Marston A, Van Vuuren S. Antimicrobial activity of southern African medicinal plants with dermatological relevance: from an ethnopharmacological screening approach, to combination studies and the isolation of a bioactive compound. J Ethnopharmacol. 2013; 148 (1): 45-55. [DOI:10.1016/j.jep.2013.03.056] [PMID]
6. Neu HC. The crisis in antibiotic resistance. Science. 1992; 257 (5073): 1064-73. [DOI:10.1126/science.257.5073.1064] [PMID]
7. Mussarat S, Adnan M, Begum S, Rehman SU, Hashem A, Abd Allah EF. Antimicrobial screening of polyherbal formulations traditionally used against gastrointestinal diseases. Saudi J Biol Sci. 2021; 28 (12): 6829-43. [DOI:10.1016/j.sjbs.2021.07.053] [PMID] [PMCID]
8. Patel SM, Saravolatz LD. Monotherapy versus combination therapy. Med Clin North Am. 2006; 90 (6): 1183-95. [DOI:10.1016/j.mcna.2006.07.008] [PMID]
9. Zhang Y, Zhang Y, Chen Z, Jia Z, Yu Y, Wang J, et al. Global burden, subtype, risk factors and etiological analysis of enteric infections from 1990-2021: population based study. Front Cell Infect Microbiol. 2025; 15: 1527765. [DOI:10.3389/fcimb.2025.1527765] [PMID] [PMCID]
10. Ilic I, Ilic M. Global patterns of trends in cholera mortality. Trop Med Infect Dis. 2023; 8 (3): 169. [DOI:10.3390/tropicalmed8030169] [PMID] [PMCID]
11. Market Research Future. Global herbal supplements market overview 2024 [Internet]. Pune (India): Market Research Future; 2024 [cited 2024 Jul 30]. Available from: https://www.marketresearchfuture.com/reports/herbal-supplements-market-3231
12. Azwanida NN. A review on the extraction methods use in medicinal plants, principle, strength and limitation. Med Aromat Plants. 2015; 4 (3): 1000196.
13. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 11th ed. CLSI standard M07. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
14. Perez C, Pauli M, Bazerque P. An antibiotic assay by the agar well diffusion method. Acta Biol Med Exp. 1990; 5 (1): 113-5.
15. Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal. 2016; 6 (2): 71-9. [DOI:10.1016/j.jpha.2015.11.005] [PMID] [PMCID]
16. Hossain TJ. Methods for screening and evaluation of antimicrobial activity: a review of protocols, advantages, and limitations. Eur J Microbiol Immunol. 2024; 14 (2): 97-115. [DOI:10.1556/1886.2024.00035] [PMID] [PMCID]
17. Nostro A, Germano MP, D'angelo V, Marino A, Cannatelli MA. Extraction methods and bioautography for evaluation of medicinal plant antimicrobial activity. Lett Appl Microbiol. 2000; 30 (5): 379-84. [DOI:10.1046/j.1472-765x.2000.00731.x] [PMID]
18. Blair JMA, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJV. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015; 13 (1): 42-51. [DOI:10.1038/nrmicro3380] [PMID]
19. Semeniuc CA, Pop CR, Rotar AM. Antibacterial activity and interactions of plant essential oil combinations against Gram-positive and Gram-negative bacteria. J Food Drug Anal. 2017; 25 (2): 403-8. [DOI:10.1016/j.jfda.2016.06.002] [PMID] [PMCID]
20. Silhavy TJ, Kahne D, Walker S. The bacterial cell envelope. Cold Spring Harb Perspect Biol. 2010; 2 (5): a000414. [DOI:10.1101/cshperspect.a000414] [PMID] [PMCID]
21. Baliah NT, Astalakshmi A. Phytochemical analysis and antibacterial activity of extracts from Terminalia chebula Retz. Int J Curr Microbiol Appl Sci. 2014; 3 (3): 992-9.
22. Mostafa M, Rahman M, Karim MM. Antimicrobial activity of Terminalia chebula. Int J Med Arom Plants. 2011; 1 (2): 175-9.
23. Aneja KR, Joshi R. Evaluation of antimicrobial properties of fruit extracts of Terminalia chebula against dental caries pathogens. Jundishapur J Microbiol. 2009; 2 (3): 105-11.
24. Zearah SA. Antifungal and antibacterial activity of flavonoid extract from Terminalia chebula Retz. fruits. J Basrah Res (Sci.). 2014; 40 (1): 122-31.
25. Sharma C, Aneja KR, Kasera R, Aneja A. Antimicrobial potential of Terminalia chebula Retz. fruit extracts against ear pathogens. World J Otorhinolaryngol. 2012; 2 (2): 8-13. [DOI:10.5319/wjo.v2.i2.8]
26. Singh D, Singh D, Choi SM, Zo SM, Ki SB, Han SS. Therapeutical effect of extracts of Terminalia chebula in inhibiting human pathogens and free radicals. Int J Biosci Biochem Bioinforma. 2012; 2 (3): 164-7. [DOI:10.7763/IJBBB.2012.V2.93]
27. Sultan MT, Anwar MJ, Imran M, Khalil I, Saeed F, Neelum S, et al. Phytochemical profile and pro-healthy properties of Terminalia chebula: a comprehensive review. Int J Food Prop. 2023; 26 (1): 526-51. [DOI:10.1080/10942912.2023.2166951]
28. Wang C, Zhang H, Wang X, Wang X, Li X, Li C, et al. Comprehensive review on fruit of Terminalia chebula: traditional uses, phytochemistry, pharmacology, toxicity, and pharmacokinetics. Molecules. 2024; 29 (23): 5547. [DOI:10.3390/molecules29235547] [PMID] [PMCID]
29. Jamil A, Pasha I, Kamran Sharif M, Israr B. Functional characterization and phytochemical profiling of Terminalia chebula fruit. J Popul Ther Clin Pharmacol. 2023; 30 (18): 2440-9.
30. Khan I, Ullah Z, Shad AA, Fahim M, Öztürk M. In vitro antioxidant, anticholinesterase inhibitory, and antimicrobial activity studies of Terminalia chebula (Retz) and Terminalia arjuna (Roxb). S Afr J Bot. 2022; 146: 395-400. [DOI:10.1016/j.sajb.2021.11.016]
31. Abdulridha MM, Abdulhussein HS, Alyaseen FF, Hassan BA. Phytochemical and antibacterial activity of the Peganum harmala seeds and its alkaloids. Plant Arch. 2019; 19 (1): 1439-44.
32. Nenaah GE. Antibacterial and antifungal activities of (beta)-carboline alkaloids of Peganum harmala (L) seeds and their combination effects. Fitoterapia. 2010; 81 (7): 779-82. [DOI:10.1016/j.fitote.2010.04.004] [PMID]
33. Wang N, An J, Zhang Z, Liu Y, Fang J, Yang Z. The Antimicrobial activity and characterization of bioactive compounds in Peganum harmala L. based on HPLC and HS-SPME-GC-MS. Front Microbiol. 2022; 13: 916371. [DOI:10.3389/fmicb.2022.916371] [PMID] [PMCID]
34. Akbar A, Ali I, Ullah S, Ullah N, Khan S, Rahman ZU, et al. Functional, antioxidant, antimicrobial potential and food safety applications of curcuma longa and cuminum cyminum. Pak J Bot. 2019; 51 (3): 1129-35. [DOI:10.30848/PJB2019-3(30)]
35. Chaudhary N, Sultana S, Ali M. Chemical composition and antimicrobial activity of volatile oil of the seeds of Cuminum cyminum L. World J Pharm Pharm Sci. 2014; 3 (1): 1428-41.
36. Sheikh MI, Islam S, Rahman A, Rahman M, Rahman M. Control of some human pathogenic bacteria by seed extracts of cumin (Cuminum cyminum L.). Agric Conspec Sci. 2010; 75 (1): 39-44.
37. Saee Y, Dadashi M, Eslami G, Goudarzi H, Taheri S, Fallah F. Evaluation of antimicrobial activity of Cuminum cyminum essential oil and extract against bacterial strains isolated from patients with symptomatic urinary tract infection. Nov Biomed. 2016; 4 (4): 147-52.
38. Mostafa AA, Al-Askar AA, Almaary KS, Dawoud TM, Sholkamy EN, Bakri M. Antimicrobial activity of some plant extracts against bacterial strains causing food poisoning diseases. Saudi J Biol Sci. 2018; 25 (2): 361-6. [DOI:10.1016/j.sjbs.2017.02.004] [PMID] [PMCID]
39. Johri RK. Cuminum cyminum and Carum carvi: an update. Pharmacogn Rev. 2011; 5 (9): 63-72. [DOI:10.4103/0973-7847.79101] [PMID] [PMCID]
40. Mundy L, Pendry B, Rahman M. Antimicrobial resistance and synergy in herbal medicine. J Herb Med. 2016; 6 (2): 53-8. [DOI:10.1016/j.hermed.2016.03.001]
41. Yadav SK, Jain GK, Mazumder A, Khar RK. Antimicrobial activity of a novel polyherbal combination for the treatment of vaginal infection. J Adv Pharm Technol Res. 2019; 10 (4): 190-4. [DOI:10.4103/japtr.JAPTR_3_19] [PMID] [PMCID]
42. Bhinge SD, Bhutkar MA, Randive DS, Wadkar GH, Todkar SS, Kakade PM, et al. Formulation development and evaluation of antimicrobial polyherbal gel. Ann Pharm Fr. 2017; 75 (5): 349-58. [DOI:10.1016/j.pharma.2017.04.006] [PMID]
43. Sheikh ZA, Khan AA, Nawaz A, Zahoor A, Siddiqui ZA, Khan SS, et al. Development and clinical evaluation of polyherbal laxative laxisen. J Pharm Pharm Sci. 2014; 2 (2): 63-70.
44. Adwan G, Abu-Shanab B, Adwan K. Antibacterial activities of some plant extracts alone and in combination with different antimicrobials against multidrug-resistant Pseudomonas aeruginosa strains. Asian Pac J Trop Med. 2010; 3 (4): 266-9. [DOI:10.1016/S1995-7645(10)60064-8]
45. Stefanović OD. Synergistic activity of antibiotics and bioactive plant extracts: a study against Gram-positive and Gram-negative bacteria [Internet]. Rijeka (Croatia): InTech; 2018 [cited 2024 Jul 30]. Available from: https://doi.org/10.5772/intechopen.72026 [DOI:10.5772/intechopen.72026.]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.